Ionis Pharmaceuticals Cash Flow Statement
NASDAQ: IONSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
45.28+1.98 (+4.57%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ionis Pharmaceuticals free cash flow
In fiscal 2025, Ionis Pharmaceuticals generated -$268.6 million of operating cash flow and spent $51.4 million on capital expenditures. That left free cash flow of -$320.0 million, a free-cash-flow margin of -33.9% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Ionis Pharmaceuticals cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -381.39M | -453.90M | -366.29M | -269.72M | -28.60M | -479.74M | 287.26M | 214.99M | -10.78M | -60.40M |
| Net Income growth (YoY) | — | — | — | — | — | -267.01% | +33.62% | — | — | — |
| Depreciation & Amortization | 10.01M | 9.61M | 10.29M | 14.33M | 15.49M | 13.37M | 12.54M | 10.71M | 6.71M | 7.48M |
| Stock-Based Compensation | 133.87M | 130.20M | 105.81M | 100.26M | 120.68M | 230.12M | 146.57M | 131.31M | 85.97M | 72.11M |
| Change in Working Capital | -131.98M | -171.76M | -14.15M | -92.06M | -92.55M | -89.90M | -185.70M | 465.65M | -28.89M | -90.38M |
| Operating Cash Flow | -268.58M | -500.95M | -307.51M | -274.37M | 30.80M | 35.89M | 345.63M | 602.91M | 174.15M | -112.11M |
| Capital Expenditures | -51.44M | -45.28M | -23.80M | -15.72M | -11.96M | -35.12M | -30.91M | -13.61M | -34.76M | -7.11M |
| Investing Cash Flow | -277.78M | -134.03M | -214.13M | -262.64M | 194.91M | 274.48M | -41.27M | -929.56M | -358.29M | 56.60M |
| Share Repurchases | — | — | — | 0 | 0 | -90.55M | -34.40M | 0 | 0 | — |
| Debt Issued | — | — | — | — | — | — | 0 | 0 | 59.75M | 0 |
| Debt Repaid | — | — | — | — | — | — | -12.50M | 0 | -3.60M | -7.07M |
| Financing Cash Flow | 675.84M | 478.06M | 644.08M | -55.30M | 245.93M | -596.61M | 100.02M | 475.87M | 229.09M | 11.39M |
| Net Change in Cash | 130.18M | -157.19M | 122.79M | -592.72M | 471.53M | -285.62M | 404.47M | 149.19M | 44.95M | -44.11M |
| Free Cash Flow | -320.03M | -546.23M | -331.32M | -290.09M | 18.84M | 772.00K | 314.72M | 589.30M | 139.38M | -119.21M |
This table shows 10 annual periods of Ionis Pharmaceuticals's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IONS's reporting calendar. What is a cash flow statement?